CSCI
COSCIENS Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · CA
$2.72
+0.00%Latest reported
- Last report date
- Aug 14, 2025
- EPS actual
- -$0.85
- EPS estimate
- —
- Revenue actual
- $2.0M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -24.0%
- Revenue beats (12Q)
- 3
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2026